This company has been marked as potentially delisted and may not be actively trading.

Kezar Life Sciences (KZR) Stock Forecast & Price Target

Get the Latest News and Ratings for KZR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KZR Analyst Ratings Over Time

Type	Current Forecast 5/29/25 to 5/29/26	1 Month Ago 4/29/25 to 4/29/26	3 Months Ago 2/28/25 to 2/28/26	1 Year Ago 5/29/24 to 5/29/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$6.00	$6.00	$6.00	$39.50
Forecasted Upside	-17.70% Downside	-17.81% Downside	-10.45% Downside	847.24% Upside
Consensus Rating	Reduce	Reduce	Reduce	Hold

KZR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KZR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kezar Life Sciences Stock vs. The Competition

Type	Kezar Life Sciences	Medical Companies	Broader Market
Consensus Rating Score	1.67	2.30	2.52
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	-17.70% Downside	1,706.92% Upside	14.48% Upside
News Sentiment Rating	Neutral News See Recent KZR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/8/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (D-)
10/17/2025	Wells Fargo & Company 3 of 5 stars	Derek Archila 4 of 5 stars	Set Target	Equal Weight	$7.00 ➝ $5.00	+19.90%
10/17/2025	Jefferies Financial Group 2 of 5 stars	Maury Raycroft Not Rated	Downgrade	Buy ➝ Hold	$18.00 ➝ $7.00	+67.87%
10/17/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Strong Sell
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Phipps Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
7/16/2025	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:13 PM ET.

KZR Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Kezar Life Sciences is $6.00, with a high forecast of $7.00 and a low forecast of $5.00.

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kezar Life Sciences in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" KZR shares.

According to analysts, Kezar Life Sciences's stock has a predicted downside of -17.70% based on their 12-month stock forecasts.

Kezar Life Sciences has been rated by research analysts at Weiss Ratings in the past 90 days.

Analysts like Kezar Life Sciences less than other "medical" companies. The consensus rating for Kezar Life Sciences is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how KZR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Kezar Life Sciences Recommendations

This page (NASDAQ:KZR) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.